The future of the National Animal Identification System (NAIS) is clarifying itself much more quickly than I ever could have imagined.

 

One of the premises of the article I recently co-authored for The Nation about NAIS is that the identification program is ultimately about enabling industry to keep tabs of genetic information—for potentially huge intellectual property riches—as cloning and transgenics take hold.

I thought that prediction was years into the future—and that the shorter-term purpose of NAIS is to enable agribusiness to consolidate its chokehold on our food supply, at the expense of small sustainable farms.

 

Yet here were are less than two weeks after the article came out, and the long-term predictions are already beginning to be realized. Two companies responsible for producing most of the cloned animals in the U.S. are proposing to market cloned products, using the NAIS as their tracking system.

 

 

No, there’s no mention of NAIS in the national news media announcements of the companies’ “voluntary” programs to begin marketing, and the national media don’t yet get the connection, but that’s what the companies are talking about.

 

Very cleverly, the biotech companies behind the new initiative—Trans Ova Genetics and ViaGen—have positioned it as “a voluntary effort” that will enable consumers to identify, and thereby avoid, cloned products. But consider this language in The Wall Street Journal article, which talks about “a tracking program” that “will have cloning companies give each cloned animal a quarter-size radio-frequency identification tag. The tag number would be entered into a registry accessible by those in the supply chain…”

 

The Washington Post article uses similar language: “The system calls for all cloned farm animals to be registered in a central tracking system and requires farmers who raise them to sign affidavits promising to keep them out of the food supply or to segregate their meat and milk so that other foods can be reliably labeled as ‘clone-free.’" (Interestingly, neither of the companies, Trans Ova or ViaGen, has an announcement about the program posted on its web site.)

 

The U.S. Food and Drug Administration hasn’t given final approval to cloned meat and milk, but look for that next, and probably sooner rather than later.